TQ0026
MDR-1339
TargetMol
DESCRIPTION
MDR-1339 (DWK-1339) is an orally active, blood-brain-barrier-permeable inhibitor of amyloid-β (Aβ) aggregation.
DETAILS
- Cas: 1018946-38-7
- Purity: 98%
- Smiles: COCCCc1ccc2oc(cc2c1)-c1ccc(OC)c(OC)c1
- Category: Compound
- Molecular Weight: 326.39
- Molecular Formula: C20H22O4
Lead Time: < 1 week
Sign in to view pricingEquivalent Items
| ... Loading